Summary
The aim of the present work was to determine experimentally the prognostic value of reduced activity of serum acetylcholinesterase (ACE) in cases of acute myocardial infarction (AMI). In the first part of the research we studied the mechanism of this reduction by comparing the serum results with the levels of the enzyme in cardiac tissue in such cases. It was found that ACE activity is reduced in serum and also in cardiac tissue in AMI, in contrast to creatine kinase (CK) that is augmented in serum but reduced in cardiac tissue. This fact was interpreted as a “reduced cardiac flow of ACE,” in contrast to the “augmented cardiac clearance of CK” in similar cases.
In the second part of our research, 50 patients, admitted in our hospital for AMI, were examined and their blood analysed mainly for ACE and CK at brief intervals (every 2–3 days), during hospitalization, and thereafter every 1–2 weeks for 1–4 months. From the results of ACE activity it was possible to classify these variations into four groups, each of them having a defined prognostic value for the evolution of the AMI, a persistent reduced serum activity being interpreted as a bad, severe prognosis, with high morbidity or mortality (groups II and III). We suggest, therefore, that the determination of ACE in serum in cases of AMI, especially before discharge home of such patients, may be an additional useful laboratory test in such cases.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bettini V, Legrenzi E, Vazzoler C, Malgherini A (1978) Effeto dell'acetilcolina in vitro su segmenti di arterie coronarie isolate di vitello. Boll Soc Ital Biol Sper 54:1642–1646
Henry RJ, Cannon DC, Winkelman JW (1974) Clinical chemistry. Principles and technics, 2nd edn. Harper and Row, New York, p 877
Kachmar JF, Moss DW (1976) Enzymes. In: Tietz NW (ed) Fundamentals of clinical chemistry. Saunders, Philadelphia, p 657
Menache R, Gaist L (1969) An improved small-scale procedure for CPK determination. Clin Chim Acta 26:591–593
Moore CB, Birchall R, Horack HM, Batson HM (1957) Changes in serum pseudocholinesterase levels in patients with diseases of the heart, liver or musculoskeletal systems. Am J Med Sci 234:538–546
Nathelson S (1971) Techniques of clinical chemistry, 3rd edn. Thomas, Springfield, Ill, p 271
Norriss RM, Whitlock RML, Barratt-Boyes C, Small CW (1975) Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction. Circulation 51:614–620
Roberts R, Henry PD, Sobel BE (1975) An improved basis for enzymatic estimation of infarct size. Circulation 52:743–754
Roe CR (1977) Validity of estimating myocardial infarction size from serial measurements of enzyme activity in the serum. Clin Chem 23:1807–1812
Roe CR, Starmer CF (1975) A sensitivity analysis of enzymatic estimation of infarct size. Circulation 52:1–5
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Menache, R., Kenda, L., Shaked, P. et al. The prognostic value of serum acetylcholinesterase in myocardial infarction. Res. Exp. Med. 181, 181–187 (1982). https://doi.org/10.1007/BF01851188
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01851188